Insilico Medicine announces Nature Medicine publication of Phase IIa results evaluating rentosertib, the novel TNIK inhibitor for idiopathic pulmonary fibrosis (IPF) discovered and designed with a pioneering AI approach - EurekAlert!
Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study of antibody-drug conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) - EurekAlert!
Two-week radiotherapy proven as safe and effective as eight-week course for prostate cancer, after 10-year follow-up in phase III trial - EurekAlert!
Single-shot simultaneous intensity, phase, and polarization imaging with metasurface - EurekAlert!
Mizzou signs agreement for first phase of new research reactor - EurekAlert!
JCOM: first phase of Janeway development completed, full migration underway - EurekAlert!
New 'Half-Ice, Half-Fire' Phase of Matter Found Lurking in a Magnet
City of Hope opens phase 1 clinical trial aim - EurekAlert
Countering the next phase of antivaccine activism - EurekAlert
NPS atomic fountain for research in quantum sensing nears completion of first phase - EurekAlert
NASA Taps SpaceX, Blue Origin for Lunar Habitat and Rover Delivery | The next phase of the Artemis program will see a Japanese rover and living quarters delivered to the lunar surface.
A phase-transformable membrane for efficient gas separation could revolutionize industrial applications - EurekAlert
NASA’s Laser Comms Demo Makes Deep Space Record, Completes First Phase
NASA's laser comms demo makes deep space record, completes first phase
NASA’s Laser Comms Demo Makes Deep Space Record, Completes First Phase
NASA Greenlights Next Phase of Italian Lunar Habitat Project
Triplet regimen yields promising response in advanced-phase chronic myeloid leukemia
Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial
Nanotubes get a boost: Liquid-phase synthesis unlock efficient production - EurekAlert
Second Phase 3 clinical trial again shows dupilumab lessens disease in COPD patients with type 2 inflammation - EurekAlert
